The aim of this study was to compare the effect of neuro-development treatment (NDT) technique and NDT plus botulinum toxin type A (BTX-A) injection on the reduction of spasticity and improvement of the quality of movement patterns of lower limb in hemiplegic patients. For this purpose, 15 hemiplegic (8 female and 7 male cases) with an age range of 27-70 years participated in this study. The pa...

The aim of this study was to compare the effect of neuro-development treatment (NDT) technique and NDT plus botulinum toxin type A (BTX-A) injection on the reduction of spasticity and improvement of the quality of movement patterns of lower limb in hemiplegic patients. For this purpose, 15 hemiplegic (8 female and 7 male cases) with an age range of 27-70 years participated in this study. The pa...

While priming is most often thought of as a strategy for modulating neural excitability to facilitate voluntary motor control, priming stimulation can also be utilized to target spinal reflex excitability. In this application, priming can be used to modulate the involuntary motor output that often follows central nervous system injury. Individuals with spinal cord injury (SCI) often experience ...

tendon jerks, resulting from hyperexcitability of the stretch reflex.”1 Spasticity can produce impairment of active functions performed by the patient such as reaching, transferring, and walking, as well as disabling symptoms of pain, spasm, and disfigurement, disturbance in passive functions when the patient is being assisted by a caregiver, such as excessive tone in a limb during washing, bat...

Oral cannabinoids for spasticity in multiple sclerosis: will attitude continue to limit use? See page 1517 Spasticity is a distressing and disabling symptom that many people with multiple sclerosis face daily because there is inadequate treatment. As one part of an upper motor-neuron syndrome, spasticity manifests as muscle stiffness, spasms, and pain. It also contributes to limited mobility an...

BACKGROUND Physical modalities such as vibration has been suggested as possible non-pharmacological way to control spasticity. AIMS The hypotheses tested were: 1) can a selective vibration of the upper limb flexor antagonist, triceps brachii, reduce the spasticity of the flexor biceps brachii muscle; 2) is its association with physiotherapy better than physiotherapy alone in reducing spastici...

Introduction: Hereditary spastic paraplegia (HSP) is the term for a group of neurological disorders characterized by progressive spasticity and muscle weakness in lower limbs. Its etiology genetic has been associated with mutations more than 60 genes. HSP rare may be useful differential diagnosis cerebral palsy. Case presentation: 16-year-old male due to mutation NIPA1 gene:c.316G>A (p. Gly1...

The development of spinal hyper-reflexia as part of the spasticity syndrome represents one of the major complications associated with chronic spinal traumatic injury (SCI). The primary mechanism leading to progressive appearance of muscle spasticity is multimodal and may include loss of descending inhibitory tone, alteration of segmental interneuron-mediated inhibition and/or increased reflex a...